safingol has been researched along with Cardiovascular Stroke in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baranowski, M; Czarnowski, D; Górski, J; Knapp, M; Lisowska, A; Musiał, W; Zabielski, P | 1 |
| Błachnio-Zabielska, A; Górski, J; Knapp, M; Kurek, K; Zabielski, P; Zendzian-Piotrowska, M | 1 |
2 other study(ies) available for safingol and Cardiovascular Stroke
| Article | Year |
|---|---|
Plasma sphingosine-1-phosphate concentration is reduced in patients with myocardial infarction.
Topics: Aged; Animals; Ceramides; Humans; Lysophospholipids; Male; Mice; Middle Aged; Myocardial Infarction; Myocytes, Cardiac; Receptors, Lysosphingolipid; Reperfusion Injury; Sphingosine; Thrombolytic Therapy | 2009 |
Myocardial infarction differentially alters sphingolipid levels in plasma, erythrocytes and platelets of the rat.
Topics: Anesthesia; Animals; Ceramides; Coronary Vessels; Erythrocyte Count; Femoral Artery; Ligation; Lysophospholipids; Male; Myocardial Infarction; Phosphotransferases (Alcohol Group Acceptor); Platelet Count; Rats; Rats, Wistar; Sphingolipids; Sphingosine; Troponin T | 2012 |